Our position in American pharmaceutical company, Eli Lilly & Company (1.8%), was a top contributor to relative returns during the fourth quarter.

For full-year 2025, 58 biotech deals worth $65.9 billion were completed compared with 73 deals worth $109 billion in all of 2024. This represents a major decline in total dollar volume and the number ...

Kinsale Capital (KNSL) shows strong revenue growth, high margins, and liquidity despite weak technicals. Read more macro analysis here.

Brokerage firm SMIFS has penciled 10 techno-funda stock picks including HAL, Infosys, ITC, PFC, LIC, L&T, BEML for 20-32 per ...